Related references
Note: Only part of the references are listed.Effects of thalidomide on isoprenaline-induced acute myocardial injury: A haemodynamic, histopathological and ultrastructural study
Harish K. Loh et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2007)
A novel anticancer effect of thalidomide:: Inhibition of intercellular adhesion molecule-1-mediated cell invasion and metastasis through suppression of nuclear factor-κB
Yi-Chu Lin et al.
CLINICAL CANCER RESEARCH (2006)
Changes in vascular reactivity following administration of isoproterenol for 1 week: a role for endothelial modulation
Ana Paula C. Davel et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Nox2 and Rac1 regulate H2O2-dependent recruitment of TRAF6 to endosomal interleukin-1 receptor complexes
QA Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Cytokines and vascular reactivity in resistance arteries
E Vila et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress
BR Clapp et al.
CARDIOVASCULAR RESEARCH (2004)
β-adrenergic stimulation induces interleukin-18 expression via β2-AR, PI3K, Akt, IKK, and NF-κB
B Chandrasekar et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Thalidomide suppresses NF-κB activation induced by TNF and H2O2, but not that activated by ceramide, lipopolysaccharides, or phorbol ester
S Majumdar et al.
JOURNAL OF IMMUNOLOGY (2002)
Irbesartan lowers superoxide levels and increases nitric oxide bioavailability in blood vessels from spontaneously hypertensive stroke-prone rats
MJ Brosnan et al.
JOURNAL OF HYPERTENSION (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Inhibition of NF-κB activity by thalidomide through suppression of IκB kinase activity
JA Keifer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice
LV d'Uscio et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by upregulation of p21Waf1 and p27Kip1
DE Marra et al.
CIRCULATION (2000)
Chronic β-adrenergic stimulation induces myocardial proinflammatory cytokine expression
DR Murray et al.
CIRCULATION (2000)
β-adrenergic blockade in developing heart failure -: Effects on myocardial inflammatory cytokines, nitric oxide, and remodeling
SD Prabhu et al.
CIRCULATION (2000)
β-adrenergic receptor blockade in chronic heart failure
MR Bristow
CIRCULATION (2000)
Cell type-specific role for reactive oxygen species in nuclear factor-kappaB activation by interleukin-1
G Bonizzi et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Antiproliferative effects of trapidil in vascular smooth muscle cells are associated by inhibition of MAPK and P34(cdc2) activity
Y Cheng et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2000)